anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Table Data

Tool collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 16,285
Current window 10,081-10,110
Pages 543
Rows per page 30
Tool: Table Dataclear collectionreset all
18 30 60

Tool

10,081-10,110 of 16,285

filter-aware
04
The slide uses a matrix-like layout to organize drug assets by therapeutic area and development stage (approved vs. pipeline).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem1 hit
09
The slide uses a grid-based layout to organize drug candidates by development stage. It includes a legend for '# Partnered and/or in collaboration' and a yellow dot for 'Precision medicine approach being explored'.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
14
The slide uses a color-coded sidebar to indicate the development stage of the drug across different therapeutic areas.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide provides a detailed overview of seven specific clinical trials (AEGEAN, ADJUVANT BR.31, PACIFIC-4, PACIFIC-5, PACIFIC-8, ADRIATIC, PACIFIC-9).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
The slide uses a standard clinical trial registry format.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide is part of an appendix, providing detailed clinical trial data for Imfinzi.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The slide uses a standard clinical trial registry format.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
The slide is part of an appendix section detailing clinical trial status for specific drug assets.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
The slide is part of an appendix, likely from a pharmaceutical investor presentation.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide uses a vertical tab structure on the right to categorize the therapeutic area (Oncology).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
22
The slide provides a structured overview of three specific clinical trials: DESTINY-Gastric04, 06, and 03.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
23
The slide is part of an appendix, indicated by the footer and the 'Other' tab in the right-hand navigation.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
24
The slide uses a standard clinical trial pipeline table format.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
25
The slide uses a standard clinical trial registry format for reporting pipeline progress.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
26
The slide uses a standard clinical trial registry format for portfolio tracking.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
27
The slide is part of an appendix, specifically detailing clinical trial status for a specific drug.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
28
The slide provides a structured overview of four specific clinical trials (LAURA, ADAURA2, NeoADAURA, FLAURA2).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
29
The slide provides a structured overview of five specific clinical trials (SAFFRON, SANOVO, SACHI, SAVANNAH, ORCHARD) including patient counts and trial arms.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
30
The slide uses a color-coded sidebar on the right to categorize the drug's development stage (Oncology).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
31
The slide provides a structured overview of five specific clinical trials (TROPION-Breast01 through 05).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
32
The slide is part of an appendix, indicated by the footer and the 'Appendix' label.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
33
The slide is part of an appendix, specifically detailing late-stage development assets in Oncology.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
34
The slide is part of an appendix, indicated by the page number 34 and the 'Appendix: Glossary' link at the bottom.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
35
The slide is part of an appendix section, indicated by the page number and glossary link.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
36
The slide is part of an appendix, detailing specific trial designs, patient counts, and status for TROPION-PanTumor trials.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
37
The slide uses a vertical navigation bar on the right to indicate the drug's development stage (Late-stage development) and therapeutic area (Oncology).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
38
Includes trial identifiers (NCT numbers) and status timelines.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
39
The slide is an appendix page detailing clinical trial pipeline data for a specific drug.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
40
The table lists five distinct clinical trials (SERENA-2, SERENA-3, NCT04541433, SERENA-1, NCT04818632).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
38
Data presented as stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit